article thumbnail

New Philips Mini TEE Ultrasound Transducer Helps Improve Cardiac Care for More Patients

DAIC

Cardiovascular ultrasound has played a key role in the evolution of early diagnosis of structural heart disease, led by a technology pioneered by Philips: the ‘transesophageal echocardiography’ (TEE) ultrasound transducer. TEE helps cardiologists by providing highly detailed images of the heart and its internal structures.

article thumbnail

Results Involving Philips FDA-cleared AI-enabled Cardiovascular Ultrasound Platform to be Presented at American Society of Echocardiography Scientific Sessions, ASE 2024

DAIC

Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.

article thumbnail

Diagnostic accuracy of artificial intelligence models in detecting congenital heart disease in the second-trimester fetus through prenatal cardiac screening: a systematic review and meta-analysis

Frontiers in Cardiovascular Medicine

Artificial intelligence (AI)-powered ultrasound provides a potential solution to improve the diagnostic accuracy of fetal CHD screening.MethodsA literature search was conducted across seven databases for systematic review. Most studies utilized deep learning models using either ultrasound or echocardiographic images.

article thumbnail

Lantheus Announces the FDA Approval of DEFINITY as Ultrasound Enhancing Agent for Use in Certain Pediatric Cardiovascular Patients

DAIC

Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly.

article thumbnail

Overcoming the Odds with Expert Fetal Cardiology Care: Zeke and Zane’s Story

Conquering CHD

As far as congenital heart diseases go, HLHS falls on the rarer end of the spectrum. Zane was diagnosed during a routine ultrasound at 20 weeks’ gestation and his mom, Kayla, was immediately referred to the Colorado Fetal Care Center (CFCC) at Childrens Hospital Colorado.

article thumbnail

What is Ultrafast Ultrasound Imaging?

All About Cardiovascular System and Disorders

Ultrasound techniques currently used in echocardiography uses frame rates from 30-150 frames/s. This limits its temporal resolution for very short lived events, especially in pediatric and congenital heart disease with faster heart rates compared to adults [1]. J Am Coll Cardiol. 2024 Jan 2;83(1):63-81. doi: 10.1016/j.jacc.2023.10.025.

article thumbnail

CHD-CXR: a de-identified publicly available dataset of chest x-ray for congenital heart disease

Frontiers in Cardiovascular Medicine

Congenital heart disease is a prevalent birth defect, accounting for approximately one-third of major birth defects. However, the emergence of deep learning in computer vision has paved the way for detecting subtle changes in chest x-rays, such as lung vessel density, enabling the detection of congenital heart disease in children.